Teva, Mylan and Perrigo: Which Combination is Most Likely?

When JPMorgan noted that Mylan (MYL), Teva Pharmaceuticals (TEVA) and Perrigo (PRGO) were the 2015 version of last year’s three-way battle between Valeant (VRX), Allergan and Actavis (ACT), they weren’t kidding. Kristoffer Tripplaar/Sipa Here’s where things stand: Teva wants to buy Mylan. Mylan doesn’t want to be bought so it’s trying to buy Perrigo, which [...]